Chronic Heart Failure (CHF)
12
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
25%
3 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
Assessment of the Impact of Clinical Decision Support Systems Included in Electronic Health Records
Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.
Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon
A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care
Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)
Dietetics Education Focused on Malnutrition Prevention
An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)
Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study
Improving Symptoms and Quality of Life in Chronic Heart Failure: Pilot Study
Depression and Quality of Life in Chronic Heart Failure Patients and the Caregivers